share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Alpern Robert J

艾伯維公司 | 4:持股變動聲明-董事 Alpern Robert J

SEC announcement ·  04/02 17:08
Moomoo AI 已提取核心訊息
In a recent transaction dated 03/31/2024, Robert J Alpern, associated with AbbVie Inc. [ABBV], has been involved in a financial activity concerning the company's stock. Unfortunately, the specific details regarding the nature of the transaction, such as the action type, status, number of shares involved, transaction price, and the resulting number of shares held after the action, have not been disclosed. This leaves a gap in the information necessary for investors to fully understand the implications of the transaction on their investment decisions.
In a recent transaction dated 03/31/2024, Robert J Alpern, associated with AbbVie Inc. [ABBV], has been involved in a financial activity concerning the company's stock. Unfortunately, the specific details regarding the nature of the transaction, such as the action type, status, number of shares involved, transaction price, and the resulting number of shares held after the action, have not been disclosed. This leaves a gap in the information necessary for investors to fully understand the implications of the transaction on their investment decisions.
在最近於2024年3月31日的一筆交易中,與艾伯維公司 [ABBV] 相關的羅伯特·阿爾珀恩參與了與該公司股票有關的金融活動。不幸的是,有關交易性質的具體細節,例如行動類型、狀態、所涉股票數量、交易價格以及行動後由此產生的持股數量,尚未披露。這在投資者充分了解交易對其投資決策的影響所必需的信息方面留下了空白。
在最近於2024年3月31日的一筆交易中,與艾伯維公司 [ABBV] 相關的羅伯特·阿爾珀恩參與了與該公司股票有關的金融活動。不幸的是,有關交易性質的具體細節,例如行動類型、狀態、所涉股票數量、交易價格以及行動後由此產生的持股數量,尚未披露。這在投資者充分了解交易對其投資決策的影響所必需的信息方面留下了空白。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息